Information Provided By: 
Fly News Breaks for October 20, 2016
IMPV
Oct 20, 2016 | 07:34 EDT
After Bloomberg reported that Imperva's sale process is on hold but that the company's sales have recovered in the last several months, RBC Capital analyst Matthew Hedberg still thinks that the company will probably be sold, but at a higher valuation. He believes that the company could be sold "in several more quarters" after its results "normalize. Hedberg estimates that the company could be acquired for $47-$52 per share. He keeps an Outperform rating on the stock.
News For IMPV From the Last 2 Days
There are no results for your query IMPV
